Aspirin intake and the use of serum ferritin as a measure of iron status

American Journal of Clinical Nutrition

Volumn 74, Issue 2, 2001, Pages 219-226

  Fleming, D J ^a   Jacques, P F ^a   Massaro, J M ^a   D'Agostino R B , Sr ^a   Wilson, P W F ^a   Wood, R J ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Antiinflammatory; Aspirin; Atherosclerosis; C reactive protein; Cytokine; Elderly; Epidemiology; Inflammation; Iron stores; Myocardial infarction; Serum ferritin

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; IRON; LIVER ENZYME; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CONTROLLED STUDY; COVARIANCE; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; FERRITIN BLOOD LEVEL; GERIATRIC PATIENT; HEART INFARCTION; HUMAN; INFLAMMATION; IRON STORAGE; LEUKOCYTE COUNT; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; THROMBOSIS PREVENTION;

EID: 0034940165     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/74.2.219     Document Type: Article

References (62)

1. Iron and the sex difference in heart disease risk
2. The iron paradigm of ischaemic heart disease
3. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men
4. Serum ferritin and risk of myocardial infarction in the elderly: The Rotterdam Study
5. Serum ferritin and ceruloplasmin as coronary risk factors
6. A prospective study of plasma ferritin and risk of myocardial infarction of US physicians
7. Plasma ferritin levels and future risk of myocardial infarction and ischemic stroke in US physicians
8. Serum ferritin and myocardial infarction
9. Low iron-binding capacity as a risk factor for myocardial infarction
10. Serum ferritin as a measure of iron stores in normal subjects
11. The relationship between marrow iron stores, plasma ferritin concentrations and iron absorption
12. Serum ferritin concentration and iron stores in normal subjects
13. A clinical evaluation of serum ferritin as an index of iron stores
14. Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron
15. The pathogenesis of atherosclerosis: A perspective for the 1990s
16. Atherosclerosis - An inflammatory disease
17. Final report on the aspirin component of the ongoing Physicians' Health Study
18. Aspirin and platelets: The antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis
19. The use of aspirin in ischemic heart disease
20. Asprin as an antiplatelet drug
21. Prentice CRM. Aspirin: Benefit and risk in thromboprophylaxis
22. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs
23. Review article: Aspirin and gastrointestinal bleeding
24. Adverse effects of low-dose aspirin in a healthy elderly population
25. Low-dose acetylsalicylic acid use and hemoglobin levels. Effects in a primary care population
26. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study
27. Iron status in Danes updated 1994. I: Prevalence of iron deficiency and iron overload in 1332 men aged 40-70 years. Influence of blood donation, alcohol intake, and iron supplementation
28. Epidemiological approaches to heart disease: The Framingham study
29. The effect of high ascorbic acid supplementation on body iron stores
30. C-reactive protein fifty years on
31. Acute-phase proteins and other systemic responses to inflammation
32. Rapid automated high sensitivity enzyme immunoassay of C-reactive protein
33. Primary iron overload
34. Laboratory testing for iron status
35. Iron overload
36. Impact of HLA-H mutations on iron stores in healthy elderly men and women
37. Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women: A protective role against iron deficiency?
38. Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women
39. Pathogenesis and treatment of the anemia of chronic disease
40. Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin
41. Progress in understanding the pathogenesis of the anemia of chronic disease
42. Pathogenesis of the anemia of chronic disease: A cytokine-mediated anemia
43. The anemia of chronic disorders
44. Serum ferritin and mean corpuscular volume as predictors of bone marrow iron stores
45. The roles of inflammation and iron deficiency as causes of anemia
46. Changes in iron metabolism with age
47. Serum ferritin in alcoholics and the relation to liver damage, iron state and erythropoietic activity
48. Plasma ferritin in old age. Influence of biological and pathological factors in a large elderly population
49. Moderate alcohol intake and nutritional status in nonalcoholic elderly subjects
50. Relationship between serum ferritin, alcohol intake, and social status in 2235 Danish men and women
51. Factors affecting the concentrations of ferritin in serum in a healthy Australian population
52. Dietary determinants of iron stores in a free-living elderly population: The Framingham Heart Study
53. Prediction of iron absorption based on iron status of female blood donors
54. A prospective study of blood donations in healthy elderly persons
55. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage
56. Nonsteroidal antiinflammatory drugs and the gastrointesstianl tract. The double-edged sword
57. A new measure, the gastric bleeding time-prolongation by aspirin in humans
58. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin
59. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men